Summary:
- The article discusses the development of new drugs, such as lecanemab and donanemab, that show promise in treating Alzheimer's disease and other forms of dementia.
- These new drugs work by targeting the buildup of amyloid proteins in the brain, which is a key factor in the development of Alzheimer's disease.
- The article highlights the potential of these drugs to usher in a new era of treatment for dementia, offering hope for patients and their families.